Medtronic and Vista to market visualisation system:
This article was originally published in Clinica
Executive Summary
Medtronic and Vista Medical Technologies are to collaborate in promoting Vista's visualisation systems for minimally invasive cardiothoracic surgery in the US. In addition, Medtronic will have exclusive distribution rights to the systems in Europe, the Middle East and Africa. Medtronic will also make an equity investment in privately-held Vista of an undisclosed amount. Vista's Series 8000 visualisation and information system incorporates 3D image acquisition with head-mounted display and real-time information integration. Vista, which is headquartered in Carlsbad, California, intends to launch the product in spring 1997.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.